Search
for
Sort by
Research 91–120 of 372
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Current evaluation of amenorrhea
- How Does pH Fit in with Oscillating Polar Growth?
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Understanding and Addressing Hair Disorders in Transgender Individuals
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
- Gender-Affirming Hormone Therapy for Transgender Men
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Polycystic ovarian syndrome
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Complications in Hair Restoration Surgery
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women
- Chronic Treatment with Minoxidil Induces Elastic Fiber Neosynthesis and Functional Improvement in the Aorta of Aged Mice
- Male hormonal contraception: looking back and moving forward
- Cross-sex hormone therapy for gender dysphoria
- Novedades terapéuticas en tricología
- Rabson-Mendenhall syndrome: two case reports and a brief review of the literature
- Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Congenital adrenal hyperplasia
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Targets to treat androgen excess in polycystic ovary syndrome
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome